Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity

HIV-1 broadly neutralizing antibodies (bNAbs) are being explored as passively administered therapeutic and preventative agents. However, the extensively diversified HIV-1 envelope glycoproteins (Env) rapidly acquire mutations to evade individual bNAbs in monotherapy regimens. The use of a “single” a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Commun
Main Authors: Steinhardt, James J., Guenaga, Javier, Turner, Hannah L., McKee, Krisha, Louder, Mark K., O’Dell, Sijy, Chiang, Chi-I, Lei, Lin, Galkin, Andrey, Andrianov, Alexander K., A. Doria-Rose, Nicole, Bailer, Robert T., Ward, Andrew B., Mascola, John R., Li, Yuxing
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5830440/
https://ncbi.nlm.nih.gov/pubmed/29491415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-03335-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados